Literature DB >> 22696320

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Pablo Perel1, Ian Roberts.   

Abstract

BACKGROUND: Colloid solutions are widely used in fluid resuscitation of critically ill patients. There are several choices of colloid and there is ongoing debate about the relative effectiveness of colloids compared to crystalloid fluids.
OBJECTIVES: To assess the effects of colloids compared to crystalloids for fluid resuscitation in critically ill patients. SEARCH
METHODS: We searched the Cochrane Injuries Group Specialised Register (searched 16 March 2012), Cochrane Central Register of Controlled Trials 2011, issue 3 (The Cochrane Library), MEDLINE (Ovid) 1946 to March 2012, Embase (Ovid) 1980 to March 2012, ISI Web of Science: Science Citation Index Expanded (1970 to March 2012), ISI Web of Science: Conference Proceedings Citation Index-Science (1990 to March 2012), PubMed (searched 16 March 2012), www.clinical trials.gov and www.controlled-trials.com. We also searched the bibliographies of relevant studies and review articles. SELECTION CRITERIA: Randomised controlled trials (RCTs) of colloids compared to crystalloids, in patients requiring volume replacement. We excluded cross-over trials and trials in pregnant women and neonates. DATA COLLECTION AND ANALYSIS: Two authors independently extracted data and rated quality of allocation concealment. We analysed trials with a 'double-intervention', such as those comparing colloid in hypertonic crystalloid to isotonic crystalloid, separately. We stratified the analysis according to colloid type and quality of allocation concealment. MAIN
RESULTS: We identified 74 eligible trials; 66 of these presented mortality data.Colloids compared to crystalloids Albumin or plasma protein fraction - 24 trials reported data on mortality, including a total of 9920 patients. The pooled relative risk (RR) from these trials was 1.01 (95% confidence interval (CI) 0.93 to 1.10). When we excluded the trial with poor quality allocation concealment, pooled RR was 1.00 (95% CI 0.92 to 1.09). Hydroxyethyl starch - 21 trials compared hydroxyethyl starch with crystalloids, n = 1385 patients. The pooled RR was 1.10 (95% CI 0.91 to 1.32). Modified gelatin - 11 trials compared modified gelatin with crystalloid, n = 506 patients. The pooled RR was 0.91 (95% CI 0.49 to 1.72). (When the trials by Boldt et al were removed from the three preceding analyses, the results were unchanged.) Dextran - nine trials compared dextran with a crystalloid, n = 834 patients. The pooled RR was 1.24 (95% CI 0.94 to 1.65).Colloids in hypertonic crystalloid compared to isotonic crystalloid Nine trials compared dextran in hypertonic crystalloid with isotonic crystalloid, including 1985 randomised participants. Pooled RR was 0.91 (95% CI 0.71 to 1.06). AUTHORS'
CONCLUSIONS: There is no evidence from RCTs that resuscitation with colloids reduces the risk of death, compared to resuscitation with crystalloids, in patients with trauma, burns or following surgery. As colloids are not associated with an improvement in survival, and as they are more expensive than crystalloids, it is hard to see how their continued use in these patients can be justified outside the context of RCTs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696320     DOI: 10.1002/14651858.CD000567.pub5

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  26 in total

Review 1.  Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Authors:  Amit Patel; Umeer Waheed; Stephen J Brett
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

2.  Fluid management in pre-eclampsia.

Authors:  John Anthony; Leann K Schoeman
Journal:  Obstet Med       Date:  2013-07-26

3.  Overview of progresses in critical care medicine 2012.

Authors:  Wei Huang; Xianyao Wan
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 4.  Perioperative fluid restriction.

Authors:  Joshua I S Bleier; Cary B Aarons
Journal:  Clin Colon Rectal Surg       Date:  2013-09

Review 5.  [State of the art in fluid and volume therapy : A user-friendly staged concept].

Authors:  M Rehm; N Hulde; T Kammerer; A S Meidert; K Hofmann-Kiefer
Journal:  Anaesthesist       Date:  2017-03       Impact factor: 1.041

Review 6.  Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury.

Authors:  Simone E Dekker; Vahagn C Nikolian; Martin Sillesen; Ted Bambakidis; Patrick Schober; Hasan B Alam
Journal:  J Neurosci Res       Date:  2017-07-25       Impact factor: 4.164

Review 7.  Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.

Authors:  David J Gattas; Arina Dan; John Myburgh; Laurent Billot; Serigne Lo; Simon Finfer
Journal:  Intensive Care Med       Date:  2013-02-14       Impact factor: 17.440

Review 8.  Reading between the (guide)lines--the KDIGO practice guideline on acute kidney injury in the individual patient.

Authors:  Mark D Okusa; Andrew Davenport
Journal:  Kidney Int       Date:  2013-09-25       Impact factor: 10.612

9.  Resuscitation with centhaquin and 6% hydroxyethyl starch 130/0.4 improves survival in a swine model of hemorrhagic shock: a randomized experimental study.

Authors:  Zinais Kontouli; Chryssoula Staikou; Nicoletta Iacovidou; Ioannis Mamais; Evaggelia Kouskouni; Apostolos Papalois; Panagiotis Papapanagiotou; Anil Gulati; Athanasios Chalkias; Theodoros Xanthos
Journal:  Eur J Trauma Emerg Surg       Date:  2018-07-13       Impact factor: 3.693

10.  Fluid management in the critically ill child.

Authors:  Sainath Raman; Mark J Peters
Journal:  Pediatr Nephrol       Date:  2013-01-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.